KM

Kapilkumar Mavjibhai Malaviya

Active Director Director DIN 10896099
DIN 10896099 First appointment Feb 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kapilkumar Mavjibhai Malaviya

Data last updated:

Kapilkumar Mavjibhai Malaviya is a Director at Pacific Bio-Tech Private Limited (since 2025). The company operates in Paper.

DIN 10896099
Primary Designation Director
Industry Paper
First Appointment 12 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pacific Bio-Tech Private Limited U21004RJ2025PTC099958
Director12 Feb 20252025Active

Board colleagues of Kapilkumar Mavjibhai Malaviya

Directorship timeline

Open interactive timeline →
Pacific Bio-Tech Private Limited
Premium access

Shareholding and investment profile for Kapilkumar Mavjibhai Malaviya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kapilkumar Mavjibhai Malaviya

Kapilkumar Mavjibhai Malaviya currently holds 1 directorship: Pacific Bio-Tech Private Limited (Director, since 12 Feb 2025).

Kapilkumar Mavjibhai Malaviya was first appointed on 12 Feb 2025 as Director at Pacific Bio-Tech Private Limited.

The current boards of Kapilkumar Mavjibhai Malaviya's companies include Akshay Samar (Pacific Bio-Tech Private Limited), Deepika Jain (Pacific Bio-Tech Private Limited), Viral Navinchandra Chauhan (Pacific Bio-Tech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available